Most quantitative assays are analog in nature, with an average signal measured from the total sample volume. The current gold standard for measuring specific DNA amounts is quantitative PCR (qPCR). qPCR utilizes specific complementary oligonucleotide primers that amplify the target of interest in combination with a fluorescent readout, based either on DNA intercalating dyes or hydrolysis-based probes (with hydrolysis probes providing additional specificity for highly stringent assays) .
However, qPCR has a number of technical limitations including the need for assay calibration with standards that are similar in quality to the samples being evaluated. This can lead to an iterative workflow process and challenges to provide qualified standards for comparison. Multiplexing assays may not be straightforward due to potential competition between assays. Also, the theoretical limit of quantification between two samples is 2-fold (corresponding to a single PCR cycle threshold), which is often not sufficient for copy number variation applications with heterogeneous material [2,3]. Typical assay sensitivities range from 1–10% for the detection of mutant gDNA in wild-type gDNA (Minor Allele Frequency or MAF), with some highly developed qPCR assays providing a limit of detection of ~0.1% MAF .
Digital PCR (dPCR) is a novel method for precise quantification of nucleic acids. It uses similar assay reagents as used in standard analog measurements, but counts the total number of individual target molecules in a digital format, enabling many applications that require high sensitivity and have restricted sample availability.
How dPCR works
Digital PCR measurements are performed by dividing the sample and qPCR assay mixture into a very large number of separate small volume reactions, such that there is either zero or one target molecule present in any individual reaction [5,6,7] (Figure 1). This is the fundamental concept for making ”digital” measurements. Thermal cycling is performed to endpoint. Any target-containing compartments will become brightly fluorescent while compartments without targets will have only background fluorescence. A reaction with no target molecule is counted as a 0 (PCR-negative), and a reaction that has one target molecule is counted as a 1 (PCR-positive). When the entire set of divided reactions is counted, the total number of ‘positive’ reactions is equal to the number of original target molecules in the entire volume, and the total number of reactions multiplied by the individual reaction volume equals the total volume assayed. Thus, the absolute concentration of the target is easily calculated as being equal to the total number of target molecules divided by the total measured volume. Uncertainty in this “absolute” measurement comes only from error in the measured volume or the presence of more than a single target molecule in a compartment, so dPCR methods which control for these two factors provide the highest accuracy.
Figure 1. Separation and digital counting provide sensitive, absolute quantification. Digital PCR is performed by dividing the sample and the assay (e.g., qPCR hydrolysis probe and primers) into enough separate reaction chambers such that any reaction will contain either only 0 or 1 target molecule. Standard endpoint PCR is performed and the number of fluorescent reactions counted. PCR-positive, "bright" reactions each contained 1 target molecule, and PCR-negative, "dark" reactions have no target.
When target molecules are divided into separate reaction compartments, the chances for more than one target molecule to be co-located in the same compartment can be calculated using Poisson statistics [8,9]. When the number of target molecules is significantly smaller than the number of compartments (low occupancy), the chance of co-compartmentalization is small. Poisson statistics can be used either as a small correction factor (at low occupancy) or it can be used to calculate an estimated concentration (at high occupancy). dPCR platforms which divide the sample into a larger number of compartments will have the highest accuracy, by directly counting single molecules (low occupancy). Similarly, dPCR performed using higher numbers of compartments provides the highest sensitivity—with limits of detection approaching 1 in a million, and the widest dynamic range of inputs—over 6 logs.
Multiplexing with dPCR
When in the digital range (where all compartments contain either 0 or 1 target molecule) it is possible to multiplex qPCR assays without concern for competition or cross reactivity, as each target-containing reaction will proceed with the target binding to its primers/probe specifically, whereas no reaction will occur in compartments without targets. Having each molecule in a separate reaction compartment allows both high and low abundance targets to be counted in the same experiment without concern for “swamping out” the low abundance target (since each compartment has at most 1 target, independent of its concentration in the average sample volume). When more than one target is counted (e.g., in a duplex assay format), ratios of the counts for one target relative to another (e.g., mutant allele vs. wild type allele) enable “absolute ratios” to be quantified, using one of the targets as an internal normalizing reference (e.g., how many amplifiable genome equivalents were loaded) that has gone through the identical experiment as the other targets assayed.
In addition, since dPCR is performed as an endpoint reaction (PCR is run to completion before measuring fluorescence), having true single target molecules in isolation allows multiplexing based on probe intensity . By adding the target-specific fluorescent assay at a limiting concentration, a compartment with that target molecule will be PCR-positive, but with a limited brightness at PCR endpoint. To count a second target type, a different target-specific probe with the same “color” is added at a higher concentration. A compartment with the second target will have a brighter signal at PCR endpoint than a compartment with the first target, enabling separate counts for each target. Combinations of both different color probes and different concentration probes can be used to multiplex at higher levels (Figure 2).
Figure 2. dPCR enables strategies for higher-plex assays. Multiple target types can be quantified within the same sample by multiplexing both with different “colors” (e.g., hydrolysis probes containing different dyes) and different “intensities” (e.g., probes with different target specificity but the same dye can be distinguished at the PCR endpoint by using different probe concentrations). Any individual reaction contains all the assays and either 0 or 1 target, precluding competition. Further multiplexing levels can be added by mixing probes with identical sequences but different dyes at specific ratios (e.g., Targets 4 and 5).
Applications for dPCR
Applications where dPCR has been demonstrated or may be well suited include: rare allele detection in heterogeneous tumors or other genetic-based diseases ; liquid biopsies of solid tumor burden using peripheral body fluids ; non-invasive prenatal diagnostics ; viral load detection ; gene expression; copy number variation in heterogeneous samples ; assays with limited sample material, such as single cell gene expression and FFPE samples; DNA quality control tests before sequencing [15,16]; and validation of low frequency mutations identified by sequencing.
- Bustin SA, Benes V, et al. (2005) Quantitative real-time RT-PCR - a perspective. J Mol Endocrinol, 34(3):597−601.
- Karlen Y, McNair A, et al. (2007) Statistical significance of quantitative PCR. BMC Bioinformatics, 8:131.
- Rutledge RG and Cote C. (2003) Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acids Res, 31(16):e93.
- Tsiatis AC, Norris-Kirby A, et al. (2010). Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications J Mol Diagn, 12:425–432.
- Sykes PJ, Neoh SH, et al. (1992). Quantitation of targets for PCR by use of limiting dilution. BioTechniques, 13:444–449.
- Vogelstein B and Kinzler KW. (1999) Digital PCR. Proc Natl Acad Sci USA, 96:9236–9241.
- Pohl G and Shih IeM. (2004) Principle and applications of digital PCR. Expert Rev Mol Diagn, 4:41–47.
- Dube S, Qin J, and Ramakrishnan R. (2008) Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device. PLoS ONE, 3(8):e2876.
- Whale AS, Huggett JF, et al. (2012) Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res, 40(11):e82.
- Zhong Q, Bhattacharya S, et al. (2011) Multiplex digital PCR: breaking the one target per color barrier of quantitative PCR. Lab Chip, 11:2167–2174.
- Pekin D, Skhiri Y, et al. (2011) Quantitative and sensitive detection of rare mutations using droplet-based microfluidics. Lab Chip, 13:2156–2166.
- Chen W, Balaj L, et al. (2013) BEAMing and droplet digital PCR analysis of mutant IDH1 mRNA in glioma patient serum and cerebrospinal fluid extracellular vesicles. Mol Ther Nucleic Acids, 2:e109; doi:10.1038/mtna.2013.28.
- Hindson BJ, Ness KD, et al. (2011) High throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem, 83:8604–8610.
- White RA 3rd, Quake SR, and Curr K. (2012) Digital PCR provides absolute quantitation of viral load for an occult RNA virus. J Virol Methods, 179:45–50.
- White RA 3rd, Blainey PC, et al. (2009) Digital PCR provides sensitive and absolute calibration for high throughput sequencing. BMC Genomics, 10:116.
- Didelot A, Kotsopoulos, et al. (2013) Multiplex picoliter-droplet digital PCR for quantitative assessment of dNA integrity in clinical samples. Clin Chem, 59(5):815–823.
About RainDance Technologies
Based in Billerica, MA, USA, RainDance Technologies is a leading life sciences company focused on improving research towards our understanding of cancers and inherited diseases through targeted sequencing and digital PCR technologies. The company’s innovative RainStorm™ digital droplet technology powers next-generation sequencing and genetic testing systems that deliver dramatically superior performance, cost, interpretability, and ease of use. RainDance systems are used routinely in major academic research institutions and hospitals around the world. Learn more about their RainDrop™ Digital PCR System at RainDanceTech.com/RainDrop.
Michael Samuels, PhD, is the Principal Research Scientist and Scientific Liaison at RainDance Technologies. He received his PhD in biochemistry from the University College London, UK, in 1999, performed Damon Runyon Fellowship-sponsored research at University of Massachusetts Medical School, Worcester, MA, USA, and has worked for over 13 years at a number of biotechnology companies.
Digital PCR—Simplifying quantitative PCR—Learn more about why digital PCR makes gene expression quantification easier and more accurate and how RainDance's use of ZENTM and LNA probes has increased their signal-to-noise ratio and rare allele detection.
Increasing ddPCR performance in low target HIV assays—ZEN Double-Quenched qPCR Probes work well in ddPCR, providing Dr Matthew Strain’s lab additional sensitivity through lower background in experiments with low copy number samples, where individual droplets matter. The Strain lab has published open-access protocols for their HIV assays that include these updated ZEN probe designs at www.bio-protocol.org.
Double-quenched probes increase sensitivity of qPCR assay detecting viral load—In this citation summary, scientists demonstrate how use of a ZEN™ Double-Quenched Probe results in a marked decrease in background fluorescence compared to a competitor’s probe containing only a single quencher. The data suggest that such double-quenched probes may be a better approach for other qPCR probe-based assays.
Two quenchers are better than one!—Review data demonstrating that use of ZEN™ and TAO™ Double-Quenched Probes in qPCR assays provides increased signal detection and greater assay sensitivity compared to use of single-quenched probes, such as probes with BHQ Quenchers. ZEN and TAO Double-Quenched Probes also make it more feasible to use longer probes due to the resulting lower background fluorescence.
Design efficient PCR and qPCR primers and probes using online tools—Find out how to facilitate experimental planning using IDT free, online tools for oligonucleotide analysis and PCR primer design. This article describes our predesigned qPCR assays and the basics of designing customized PCR primers and hydrolysis probes with the PrimerQuest® Tool.
Review other DECODED Online newsletter articles on qPCR advice and applications.
You can also browse our DECODED Online newsletter for additional application reviews, lab tips, and citation summaries to facilitate your research.
Product focus: Assays, probes, and tools for dPCR
PrimeTime® qPCR Assays
- 5′ nuclease, probe-based assays—the gold standard for quantitative gene expression studies
- Primer-based assays—designed for intercalating dye experiments
Create custom assays that are designed using our proprietary bioinformatics algorithms for any target and to your specific parameters. Alternatively, select one of our predesigned assays for human, mouse, and rat mRNA targets that are supported by our bioinformatics algorithms and up-to-date sequence information.
Learn more at www.idtdna.com/PrimeTime. For assistance with assay design, contact our scientific application specialists at email@example.com.
ZEN™ and TAO™ Double-Quenched Probes have a 5′ fluorophore, an internal quencher (ZEN or TAO quencher), and Iowa Black FQ as the 3′ quencher. These probes provide consistently earlier Cq values and improved precision, when compared to traditional, single-quenched qPCR probes.
Learn more at www.idtdna.com/qPCRprobes.
Free tools for qPCR and PCR assay design
Explore IDT free, online tools for qPCR probe design and analysis. The design engines for these tools use sophisticated formulas that, for example, take into account nearest neighbor analysis to calculate Tm, and provide the very best qPCR assay designs.
Author: Ellen Prediger, PhD, is a senior scientific writer at IDT.
© 2013, 2016 Integrated DNA Technologies. All rights reserved. Trademarks contained herein are the property of Integrated DNA Technologies, Inc. or their respective owners. For specific trademark and licensing information, see www.idtdna.com/trademarks.